Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 114
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05907980 | A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors | ||
| NCT00976170 | Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) | ||
| NCT05904886 | A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) | ||
| NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT00746317 | A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) | ||
| NCT07617337 | AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer | ||
| NCT02795767 | A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors | ||
| NCT04708847 | A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer | ||
| NCT00661284 | A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) | ||
| NCT00628043 | Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | ||
| NCT00144508 | Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) | ||
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | ||
| NCT04511845 | A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). | ||
| NCT07107490 | A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER | ||
| NCT00470223 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | ||
| NCT06497556 | A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT02965053 | A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis | ||
| NCT04963270 | A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis | ||
| NCT05425446 | Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients | ||
| NCT00144482 | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy | ||
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | ||
| NCT00144651 | Study of MRA in Patients With Rheumatoid Arthritis (RA) | ||
| NCT05022927 | A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma | ||
| NCT01986933 | A Phase 2 Study of CIM331 for Atopic Dermatitis Patients | ||
| NCT02748837 | A Study of ERY974 in Patient With Advanced Solid Tumors | ||
| NCT07030959 | Study of AUBE00 in Patients With Solid Tumors | ||
| NCT00433693 | Correction Study of R744 in Renal Anemia Patients on Hemodialysis | ||
| NCT00433849 | Clinical Study of R744 to Peritoneal Dialysis Patients | ||
| NCT01713842 | Tocilizumab Effect iN pOlymyalgia Rheumatica | ||
| NCT00144456 | A New Active Vitamin D, ED-71 for Osteoporosis | ||
| NCT04338269 | A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment | ||
| NCT07239336 | Study of DONQ52 in Active Celiac Disease | ||
| NCT02101333 | Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis | ||
| NCT04958265 | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | ||
| NCT01656525 | A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients | ||
| NCT02514681 | A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer | ||
| NCT04740905 | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion | ||
| NCT05735366 | A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors | ||
| NCT07416526 | A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A | ||
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | ||
| NCT03726879 | A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer | ||
| NCT00144599 | Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) | ||
| NCT04740931 | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion | ||
| NCT03020160 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A | ||
| NCT06793553 | Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC | ||
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | ||
| NCT01989780 | Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | ||
| NCT06723106 | Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) | ||
| NCT02028884 | Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) | ||
| NCT05269667 | A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention |
